{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:22:25Z","timestamp":1793380945262,"version":"4.5.0"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition observed globally, with the potential to progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and even hepatocellular carcinoma. Currently, the US Food and Drug Administration (FDA) has not approved any drugs for the treatment of NAFLD. NAFLD is characterized by histopathological abnormalities in the liver, such as lipid accumulation, steatosis, hepatic balloon degeneration, and inflammation. Dysbiosis of the gut microbiota and its metabolites significantly contribute to the initiation and advancement of NAFLD.\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    , a potential probiotic, has shown strong potential in preventing the onset and progression of NAFLD. However, the precise mechanism by which\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    treats NAFLD remains uncertain. In this review, we explore the current understanding of the role of\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    and its metabolites in the treatment of NAFLD, focusing on their ability to reduce liver inflammation, mitigate hepatic steatosis, and enhance intestinal barrier function. Additionally, we summarize how\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    alleviates pathological changes by restoring the metabolism, improving insulin resistance, regulating cytokines, and promoting tight-junctions. A deeper comprehension of the mechanisms through which\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    is involved in the pathogenesis of NAFLD should aid the development of innovative drugs targeting NAFLD.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2024.1288856","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:46:07Z","timestamp":1710920767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Bacteroides and NAFLD: pathophysiology and therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jcmgh.2022.08.001","article-title":"Sex-dependent hepatoprotective role of IL-22 receptor signaling in non-alcoholic fatty liver disease-related fibrosis.","volume":"14","author":"Abdelnabi","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1037696","article-title":"Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: a systematic review.","volume":"9","author":"Amiri","year":"2022","journal-title":"Front. Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases.","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest Surg."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice.","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"B5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030717","article-title":"Beneficial effects of viable and heat-inactivated Lactobacillus rhamnosus GG administration on oxidative stress and inflammation in diet-induced NAFLD in rats.","volume":"12","author":"Arellano-Garcia","year":"2023","journal-title":"Antioxidants"},{"key":"B7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10557-019-06904-x","article-title":"State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications.","volume":"33","author":"Azemawah","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc13c01s9","article-title":"Laboratory maintenance and cultivation of bacteroides species","author":"Bacic","year":"2008","journal-title":"Curr. Protoc. Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"fuab054","DOI":"10.1093\/femsre\/fuab054","article-title":"Gut biofilms: Bacteroides as model symbionts to study biofilm formation by intestinal anaerobes.","volume":"46","author":"B\u00e9chon","year":"2022","journal-title":"FEMS Microbiol. Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9321643","article-title":"Gut Microbiota as a driver of inflammation in nonalcoholic fatty liver disease.","volume":"2018","author":"Bibbo","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182827","article-title":"Age-related NAFLD: the use of probiotics as a supportive therapeutic intervention.","volume":"11","author":"Campagnoli","year":"2022","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-generation beneficial microbes: the case of Akkermansia muciniphila.","volume":"8","author":"Cani","year":"2017","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): a systematic review.","volume":"23","author":"Carpi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD.","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.PSIB-0001-2018","article-title":"Outer membrane vesicle-host cell interactions.","volume":"7","author":"Cecil","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2196\/34809","article-title":"The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019.","volume":"8","author":"Chen","year":"2022","journal-title":"JMIR Public Health Surveill."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.108943","article-title":"Tangeretin prevents obesity by modulating systemic inflammation, fat browning, and gut microbiota in high-fat diet-induced obese C57BL\/6 mice.","volume":"101","author":"Chen","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12026-007-8014-9","article-title":"Th17 cells: a new fate for differentiating helper T cells.","volume":"41","author":"Chen","year":"2008","journal-title":"Immunol. Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201948354","article-title":"Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice.","volume":"50","author":"D\u2019Alessandro","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1210\/en.2006-0417","article-title":"Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.","volume":"147","author":"den Boer","year":"2006","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice.","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010019","article-title":"Microbial fermentation of dietary protein: an important factor in diet\u2013microbe\u2013host interaction.","volume":"7","author":"Diether","year":"2019","journal-title":"Microorganisms"},{"key":"B27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon.","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.2174\/1381612825666190117114305","article-title":"The role of statins in the management of nonalcoholic fatty liver disease.","volume":"24","author":"Doumas","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00868-z","article-title":"Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease.","volume":"8","author":"Durant","year":"2020","journal-title":"Microbiome"},{"key":"B30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrmicro3050","article-title":"The abundance and variety of carbohydrate-active enzymes in the human gut microbiota.","volume":"11","author":"El Kaoutari","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000492853","article-title":"Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy.","volume":"49","author":"Feng","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145503","article-title":"Safety assessment of Bacteroides uniformis CECT 7771 isolated from stools of healthy breast-fed infants.","volume":"11","author":"Fern\u00e1ndez-Murga","year":"2016","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijbiomac.2021.04.069","article-title":"A comprehensive review on the impact of \u03b2-glucan metabolism by Bacteroides and Bifidobacterium species as members of the gut microbiota.","volume":"181","author":"Fernandez-Julia","year":"2021","journal-title":"Int. J. Biol. Macromol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.","volume":"66","author":"Ferrere","year":"2017","journal-title":"J. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract.","volume":"15","author":"Foley","year":"2019","journal-title":"PLoS Pathog."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1050271","article-title":"Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells.","volume":"13","author":"Fonseca","year":"2022","journal-title":"Front. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.ajpath.2015.01.018","article-title":"PPAR\u03b1-deficient ob\/ob obese mice become more obese and manifest severe hepatic steatosis due to decreased fatty acid oxidation.","volume":"185","author":"Gao","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041079","article-title":"Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.","volume":"7","author":"Gauffin Cano","year":"2012","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.3350\/cmh.2022.0373","article-title":"Bariatric surgery for non-alcoholic fatty liver disease: indications and post-operative management.","volume":"29","author":"Geerts","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7010012","article-title":"Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth?","volume":"7","author":"Hadi","year":"2018","journal-title":"Antioxidants"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1128\/jb.01780-14","article-title":"Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe.","volume":"196","author":"Heinken","year":"2014","journal-title":"J. Bacteriol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.biotechadv.2017.12.005","article-title":"Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction.","volume":"36","author":"Hor\u00e1\u010dkov\u00e1","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women.","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions.","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"B45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis.","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2023.217","article-title":"Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control.","author":"Igi","year":"2024","journal-title":"Clin. Endosc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MCG.0b013e31827873dc","article-title":"Immune therapy for nonalcoholic steatohepatitis: are we there yet?","volume":"47","author":"Ilan","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3350\/cmh.2015.21.4.319","article-title":"Nitric oxide in liver fibrosis: the role of inducible nitric oxide synthase.","volume":"21","author":"Iwakiri","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081712","article-title":"Gut microbiota-derived components and metabolites in the progression of Non-Alcoholic Fatty Liver Disease (NAFLD).","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1017\/s0007114516004025","article-title":"Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation.","volume":"116","author":"Jin","year":"2016","journal-title":"Br. J. Nutr."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1113643","article-title":"Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease.","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut.","volume":"111","author":"Joyce","year":"","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4161\/19490976.2014.969986","article-title":"Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk.","volume":"5","author":"Joyce","year":"","journal-title":"Gut Microbes"},{"key":"B56","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00017.2023","article-title":"Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.","volume":"325","author":"Kaufmann","year":"2023","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrgastro.2017.181","article-title":"NAFLD in 2017: novel insights into mechanisms of disease progression.","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/life12030354","article-title":"Taurine ameliorates tunicamycin-induced liver injury by disrupting the vicious cycle between oxidative stress and endoplasmic reticulum stress.","volume":"12","author":"Kim","year":"2022","journal-title":"Life"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH.","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14218\/jcth.2019.00051","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations.","volume":"8","author":"Kumar","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/apha.12365","article-title":"Physiological role of taurine\u2013from organism to organelle.","volume":"213","author":"Lambert","year":"2015","journal-title":"Acta Physiol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/nu15133039","article-title":"Effect of a probiotic and a synbiotic on body fat mass, body weight and traits of metabolic syndrome in individuals with abdominal overweight: a human, double-blind, randomised, controlled clinical study.","volume":"15","author":"Laue","year":"2023","journal-title":"Nutrients"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119324","article-title":"Therapeutic mechanisms and clinical effects of glucagon-like peptide 1 receptor agonists in nonalcoholic fatty liver disease.","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/nu13092989","article-title":"Amelioration of hepatic steatosis in mice through Bacteroides uniformis CBA7346-mediated regulation of high-fat diet-induced insulin resistance and lipogenesis.","volume":"13","author":"Lee","year":"2021","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13294","article-title":"Bariatric surgery and the liver\u2014mechanisms, benefits, and risks.","volume":"22","author":"Lefere","year":"2021","journal-title":"Obes. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.2147\/dddt.s379335","article-title":"Atorvastatin inhibits high-fat diet-induced lipid metabolism disorders in rats by inhibiting Bacteroides reduction and improving metabolism.","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41423-022-00871-4","article-title":"Bacteroides ovatus-mediated CD27(-) MAIT cell activation is associated with obesity-related T2D progression.","volume":"19","author":"Li","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism.","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"B69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2021.03.005","article-title":"IFN-\u03b3 contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1\u03b2\/TLR2 signaling pathway.","volume":"134","author":"Li","year":"2021","journal-title":"Mol. Immunol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108970","article-title":"SIRT2 deficiency aggravates diet-induced nonalcoholic fatty liver disease through modulating gut microbiota and metabolites.","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215302","article-title":"The positive effects of grifola frondosa heteropolysaccharide on NAFLD and regulation of the gut microbiota.","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms.","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106476","article-title":"Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared metabolic pathways.","volume":"26","author":"Lin","year":"2023","journal-title":"iScience"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090435","article-title":"Raw bowl tea (Tuocha) polyphenol prevention of nonalcoholic fatty liver disease by regulating intestinal function in mice.","volume":"9","author":"Liu","year":"2019","journal-title":"Biomolecules"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1865706","article-title":"Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice.","volume":"13","author":"L\u00f3pez-Almela","year":"2021","journal-title":"Gut Microbes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.","volume":"11","author":"Lopez-Siles","year":"2017","journal-title":"ISME J."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1110536","article-title":"Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies.","volume":"10","author":"Maestri","year":"2023","journal-title":"Front. Nutr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.4254\/wjh.v14.i9.1704","article-title":"Non-alcoholic fatty liver disease: is surgery the best current option and can novel endoscopy play a role in the future?","volume":"14","author":"Mandour","year":"2022","journal-title":"World J. Hepatol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art.","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview.","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108174","article-title":"The extracellular vesicle generation paradox: a bacterial point of view.","volume":"40","author":"McMillan","year":"2021","journal-title":"EMBO J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.585066","article-title":"Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice.","volume":"11","author":"Mu","year":"2020","journal-title":"Front. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30114-4","article-title":"Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome.","volume":"8","author":"Nagpal","year":"2018","journal-title":"Sci. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrgastro.2016.170","article-title":"Bariatric surgery for obesity and metabolic disorders: state of the art.","volume":"14","author":"Nguyen","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"15518","DOI":"10.3748\/wjg.v20.i42.15518","article-title":"Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.","volume":"20","author":"Paolella","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","article-title":"Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.","volume":"16","author":"Paredes-Turrubiarte","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116896","article-title":"Outer-inner membrane vesicles naturally secreted by gram-negative pathogenic bacteria.","volume":"10","author":"Perez-Cruz","year":"2015","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.nutr.27.061406.093618","article-title":"ChREBP, a transcriptional regulator of glucose and lipid metabolism.","volume":"27","author":"Postic","year":"2007","journal-title":"Annu. Rev. Nutr."},{"key":"B93","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.3748\/wjg.v26.i48.7603","article-title":"Gut microbiota mediated molecular events and therapy in liver diseases.","volume":"26","author":"Qi","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108005","article-title":"Activation of a specific gut Bacteroides-folate-liver axis benefits for the alleviation of nonalcoholic hepatic steatosis.","volume":"32","author":"Qiao","year":"2020","journal-title":"Cell Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17626","article-title":"The evolution of cooperation within the gut microbiota.","volume":"533","author":"Rakoff-Nahoum","year":"2016","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245212","article-title":"Lactiplantibacillus plantarum DSM20174 attenuates the progression of non-alcoholic fatty liver disease by modulating gut microbiota, improving metabolic risk factors, and attenuating adipose inflammation.","volume":"14","author":"Riezu-Boj","year":"2022","journal-title":"Nutrients"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111836","article-title":"Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: features of gut microbiome-liver-adipose tissue axis.","author":"Romualdo","year":"2022","journal-title":"Nutrition"},{"key":"B99","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2089006","article-title":"Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease.","volume":"14","author":"Sangineto","year":"2022","journal-title":"Gut Microbes"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1123547","DOI":"10.3389\/fmicb.2023.1123547","article-title":"Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet.","volume":"14","author":"Shin","year":"2023","journal-title":"Front. Microbiol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3679-7","article-title":"Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol.","volume":"20","author":"Silva-Sperb","year":"2019","journal-title":"Trials"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121685","article-title":"Gut microbiome as a therapeutic target for liver diseases.","volume":"322","author":"Singh","year":"2023","journal-title":"Life Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/jci134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B106","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","article-title":"Therapeutic potential of fecal microbiota transplantation.","volume":"145","author":"Smits","year":"2013","journal-title":"Gastroenterology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00533-22","article-title":"The proteome of extracellular vesicles produced by the human gut bacteria Bacteroides thetaiotaomicron in vivo is influenced by environmental and host-derived factors.","volume":"88","author":"Stentz","year":"2022","journal-title":"Appl. Environ. Microbiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.foodres.2019.108590","article-title":"A potential species of next-generation probiotics? The dark and light sides of Bacteroides fragilis in health.","volume":"126","author":"Sun","year":"2019","journal-title":"Food Res. Int"},{"key":"B109","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.foodres.2018.08.088","article-title":"Investigations of Bacteroides spp. towards next-generation probiotics.","volume":"116","author":"Tan","year":"","journal-title":"Food Res. Int."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00253-019-09617-1","article-title":"Novel strains of Bacteroides fragilis and Bacteroides ovatus alleviate the LPS-induced inflammation in mice.","volume":"103","author":"Tan","year":"","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0214-1","article-title":"Is serum Interleukin-17 associated with early atherosclerosis in obese patients?","volume":"12","author":"Tarantino","year":"2014","journal-title":"J. Transl. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000282083","article-title":"The role of cytokines in non-alcoholic fatty liver disease.","volume":"28","author":"Tilg","year":"2010","journal-title":"Dig. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2741\/3603","article-title":"Beneficial effects of Bacteroides fragilis polysaccharides on the immune system.","volume":"15","author":"Troy","year":"2010","journal-title":"Front. Biosci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest.","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiy186","article-title":"Mucin degradation niche as a driver of microbiome composition and Akkermansia muciniphila abundance in a dynamic gut model is donor independent.","volume":"94","author":"Van Herreweghen","year":"2018","journal-title":"FEMS Microbiol. Ecol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1039\/d1fo00875g","article-title":"The roles of different Bacteroides fragilis strains in protecting against DSS-induced ulcerative colitis and related functional genes.","volume":"12","author":"Wang","year":"","journal-title":"Food Funct."},{"key":"B117","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1080\/10408398.2020.1802695","article-title":"Roles of intestinal bacteroides in human health and diseases.","volume":"61","author":"Wang","year":"","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.663325","article-title":"Bacteroides fragilis polysaccharide a ameliorates abnormal voriconazole metabolism accompanied with the inhibition of TLR4\/NF-\u03baB pathway.","volume":"12","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2027853","article-title":"Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury.","volume":"14","author":"Wang","year":"2022","journal-title":"Gut Microbes"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.923599","article-title":"The role of gut microbiota in some liver diseases: from an immunological perspective.","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.26","article-title":"An insider\u2019s perspective: Bacteroides as a window into the microbiome.","volume":"2","author":"Wexler","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-11-61","article-title":"Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.","volume":"11","author":"Wrzosek","year":"2013","journal-title":"BMC Biol."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02517-22","article-title":"Bacteroides vulgatus ameliorates lipid metabolic disorders and modulates gut microbial composition in hyperlipidemic rats.","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155200","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway.","volume":"131","author":"Yan","year":"2022","journal-title":"Metabolism"},{"key":"B126","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/mi.2016.42","article-title":"Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice.","volume":"10","author":"Yang","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/circulationaha.118.033714","article-title":"Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis.","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103342","article-title":"Bacteroides spp. promotes branched-chain amino acid catabolism in brown fat and inhibits obesity.","volume":"24","author":"Yoshida","year":"2021","journal-title":"iScience"},{"key":"B129","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/j.gastro.2022.09.040","article-title":"Bacteroides vulgatus SNUG 40005 restores Akkermansia depletion by metabolite modulation.","volume":"164","author":"You","year":"2023","journal-title":"Gastroenterology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease.","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121912","article-title":"Therapeutic opportunities of IL-22 in non-alcoholic fatty liver disease: from molecular mechanisms to clinical applications.","volume":"9","author":"Zai","year":"2021","journal-title":"Biomedicines"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49462-w","article-title":"Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities.","volume":"9","author":"Zeng","year":"2019","journal-title":"Sci. Rep."},{"key":"B134","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13238-017-0436-0","article-title":"New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/cm9.0000000000002711","article-title":"Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds","volume":"136","author":"Zhang","year":"2023","journal-title":"Chin. Med. J. (Engl)"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03330-22","article-title":"Amelioration of colitis by a gut bacterial consortium producing anti-inflammatory secondary bile acids.","volume":"11","author":"Zhou","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/asj.12937","article-title":"Regulation of intestinal health by branched-chain amino acids.","volume":"89","author":"Zhou","year":"2018","journal-title":"Anim. Sci. J."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1063699","article-title":"Bacteroides fragilis strain ZY-312 promotes intestinal barrier integrity via upregulating the STAT3 pathway in a radiation-induced intestinal injury mouse model.","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Nutr."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1288856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T07:46:12Z","timestamp":1710920772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1288856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":138,"alternative-id":["10.3389\/fmicb.2024.1288856"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1288856","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"1288856"}}